艾司西酞普兰对心脏X综合征合并焦虑抑郁障碍患者的疗效观察-现代医学

艾司西酞普兰对心脏X综合征合并焦虑抑郁障碍患者的疗效观察

单位：1. 郑州大学附属洛阳中心医院心血管内科, 河南洛阳 471009;
2. 郑州大学附属洛阳中心医院超声科, 河南洛阳 471009

分类号：R541.9

出版年·卷·期（页码）：2019·47·第十二期（1451-1455）

摘要：

目的： 观察艾司西酞普兰对伴有焦虑抑郁障碍的心脏X综合征（CSX）患者的治疗效果。方法： 选择2013年10月至2018年2月在郑州大学附属洛阳中心医院心内科住院的合并焦虑抑郁障碍的CSX患者96例，随机分为治疗组和对照组各48例。两组均接受常规治疗，治疗组加用艾司西酞普兰片，10 mg，1次·d^-1，共用药6个月。比较两组患者治疗后的汉密尔顿焦虑评分（Hamilton Anxiety Scale，HAMA）降低值、17项汉密尔顿抑郁评分（Hamilton Depression Scale-17，HAMD₁₇）降低值、再次住院率、运动试验阳性率、运动试验开始至运动试验阳性时间、血常规、血清内皮素-1水平等指标。结果： 治疗组HAMA评分降低值（10.26±3.56）及HAMD₁₇评分降低值（8.5±4.12）均明显高于对照组，差异有统计学意义（P<0.05）。治疗后治疗组运动试验开始至运动试验阳性时间较对照组明显延长，差异有统计学意义（P<0.05）。随访期间治疗组再次入院率为2.12%，对照组为13.04%，差异有统计学意义（P<0.05）。治疗组未出现严重不良反应。结论： 对伴有焦虑抑郁障碍的CSX患者，在常规治疗基础上加用艾司西酞普兰，可明显改善患者的心理状态，改善其运动耐量，降低再入院率。

Objective: To observe the efficacy of Escitalopram in treating patients with cardiac syndrome X(CSX) combined anxiety and depression. Methods: A total of 96 CSX patients combined with anxiety and depression admitted to the Department of Cardiology, Luoyang Central Hospital Affiliated to Zhengzhou University from October 2013 to February 2018 were randomly divided into treatment group and control group,with 48 cases in each group. Both groups received conventional treatment, and the treatment group was additionally treated with Escitalopram tablets, 10 mg once a day for a total of 6 months. The reduction of Hamilton Rating Scale for Anxiety (HAMA) and 17 items Hamilton Rating Scale for Depression (HAMD₁₇) after treatment, the rate of re-hospitalization, the rate of tread mill exercise test, the time from the start of exercise test to the positive exercise test, blood routine, endothelin-1 level and other indicators in the two groups were observed respectively. Results: After treatment,HAMA score reduction (10.26±3.56) and HAMD₁₇ score reduction (8.5±4.12) in the treatment group were significantly higher than those in the control group (P<0.05). Compared with the state before the treatment, the time from the start of the exercise test to the positive exercise test was longer in both groups,but the effect of the treatment group was better than control group.During the follow-up period, the readmission rate of the treatment group was 2.12%,which was significantly different from that of the control group (13.04%,P<0.05). No serious adverse reactions was observed in the treatment group.Conclusion: ForCSX patients combined with anxiety and depression,the addition of Escitalopram on the basis of conventional treatment can significantly improve the psychological state of patients,improve exercise tolerance,reduce the readmission rate.

参考文献：

[1] 刘启明.微血管性心绞痛研究进展[J].国外医学生理、病理科学与临床分册,1999(2):129-131.
[2] FORD T J,ROCCHICCIOLI P,GOOD R,et al.Systemic microvascular dysfunction in microvascular and vasospastic angina[J].Eur Heart J,2018,39(46):4086-4097.
[3] ROSANO G M,COLLINS P,KASKI J C,et al.Syndrome X in women is associated with oestrogen deficiency[J].Eur Heart J,1995,16(5):610-614.
[4] ASBURY E A,CREED F,COLLINS P.Distinct psychosocial differences between women with coronary heart disease and cardiac syndrome X[J].Eur Heart J,2004,25(19):1695-1701.
[5] 冯占斌,李崇民,成蕊宁,等.CSX患者焦虑抑郁情况调查分析[J].心脏杂志,2010,22(1):114-116.
[6] LANZA G A.Cardiac syndrome X:a critical overview and future perspectives[J].Heart,2007,93(2):159-166.
[7] KEMP H P.Left ventricular function in patients with the anginal syndrome and normal coronary arteriograms[J].Am J Cardiol,1973,32(3):375-376.
[8] 高展,高润霖,陈纪林,等.CSX患者长期随访研究[J].中华心血管病杂志,2004,32(6):483-485.
[9] HUMPHRIES K H,PU A,GAO M,et al.Angina with "normal" coronary arteries:sex differences in outcomes[J].Am Heart J,2008,155(2):375-381.
[10] JESPERSEN L,HVELPLUND A,ABILDSTROM S Z,et al.Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events[J].Eur Heart J,2012,33(6):734-744.
[11] GULLI G,CEMIN R,PANCERA P,et al.Evidence of parasympathetic impairment in some patients with cardiac syndrome X[J].Cardiovasc Res,2001,52(2):208-216.
[12] SMITH P J,BLUMENTHAL J A,HINDERLITER A L,et al.Microvascular endothelial function and neurocognition among adults with major depressive disorder[J].Am J Geriatr Psychiatry,2018,26(10):1061-1069.
[13] 王中立,戴建国,侍昊,等.恐惧、焦虑、抑郁情绪对小鼠机械性痛阈的影响[J].东南大学学报(医学版),2016,35(2):186-188.
[14] BERTA T,PARK C K,XU Z Z,et al.Extracellular caspase-6 drives murine inflammatory pain via microglial TNF-αsecretion[J].J Clin Invest,2014,124(3):1173-1186.
[15] HAAPAKOSKI R,MATHIEU J,EBMEIER K P,et al.Cumulative meta-analysis of interleukins 6 and 1β,tumour necrosis factor α and C-reactive protein in patients with major depressive disorder[J].Brain Brain Behav Immun,2015,49:206-215.
[16] KIM B J,CHO I S,CHO K I.Impact of mindfulness based stress reduction therapy on myocardial function and endothelial dysfunction in female patients with microvascular angina[J].J Cardiovasc Ultrasound,2017,25(4):118-123.
[17] 王琳,邓鹤秋,黄丛萍,等.氟哌噻吨美利曲辛联合地尔硫卓治疗围绝经期CSX的对比研究[J].中国妇幼保健,2010,25(36):5427-5429.
[18] 陈洁,葛梦娜.丙戊酸钠与草酸艾司西酞普兰联合治疗特发性癫痫合并抑郁的临床疗效及安全性[J].现代医学,2018,46(9):997-1002.

服务与反馈：

【文章下载】【发表评论】【查看评论】【加入收藏】

提示：您还未登录，请登录！点此登录